Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development

Published:2024-07-09 Issue:8 Volume:33 Page:801-814
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Cruciani Claudio¹,Gatto Mariele²,Iaccarino Luca¹,Doria Andrea¹^ORCID,Zen Margherita¹

Affiliation:

1. Rheumatology Unit, Department of Medicine, University of Padua, Padova, Italy

2. Rheumatology Unit, Department of Clinical and Biological Sciences, University of Turin and Turin Mauriziano Hospital, Turin, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2376566

Reference127 articles.

1. Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakiset al

2. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis

3. Independent association of glucocorticoids with damage accrual in SLE

4. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

5. Etanercept Therapy in Rheumatoid Arthritis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP